CDC Updates Practice Recommendations for Contraceptives
By Elana Gotkine HealthDay Reporter
FRIDAY, Aug. 9, 2024 -- In two practice recommendations published in the Aug. 8 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report, updated recommendations are presented relating to use of specific contraceptive methods and for persons with certain characteristics or medical conditions.
Kathryn M. Curtis, Ph.D., from the CDC in Atlanta, and colleagues updated recommendations for health care providers relating to initiation and use of specific contraceptive methods after a review of the evidence. The updates include recommendations for provision of medications for intrauterine device placement; recommendations for bleeding irregularities during use of implants; recommendations for use of testosterone and risk for pregnancy; and recommendations for injectable contraception self-administration.
Antoinette T. Nguyen, M.D., also from the CDC, and colleagues updated recommendations for the use of specific contraceptive methods by persons with certain characteristics or medical conditions. Updates include the addition of recommendations for individuals with chronic kidney disease; revisions to the recommendations for persons with specific characteristics or conditions, including breastfeeding, postpartum, obesity, surgery, high risk for HIV infection, cirrhosis, liver tumor, sickle cell disease, and solid organ transplantation; and inclusion of new contraceptive methods, such as new combined oral contraceptives, contraceptive patches, vaginal rings, progestin-only pills, levonorgestrel intrauterine devices, and vaginal pH modulators.
"Voluntary informed choice of contraceptive methods is an essential guiding principle of these recommendations, and person-centered contraceptive counseling can help to ensure a person's contraceptive needs are met successfully," Nguyen and colleagues write.
U.S. Selected Practice Recommendations for Contraceptive Use, 2024
U.S. Medical Eligibility Criteria for Contraceptive Use, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.